Skip to main content
PolyPeptide Group AG logo

PolyPeptide Group AG — Investor Relations & Filings

Ticker · PPGN ISIN · CH1110760852 LEI · 5067007JCKTPOX4G9758 SW Manufacturing
Open in API
Filings indexed 111 across all filing types
Latest filing 2024-08-08 Board/Management Inform…
Country CH Switzerland
Listing SW PPGN

About PolyPeptide Group AG

https://www.polypeptide.com/

PolyPeptide Group AG is a Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company serves the pharmaceutical and biotech sectors by providing a comprehensive range of services that cover all stages of product development, from pre-clinical to commercial manufacturing. Its offerings include both proprietary (custom) and generic GMP-grade peptides. PolyPeptide focuses on innovation in peptide synthesis and manufacturing processes to support the development of therapies for patients.

Recent filings

Filing Released Lang Actions
PolyPeptide appoints Chief Commercial Officer
Board/Management Information Classification · 100% confidence The document is a 'Media release' dated August 8, 2024, announcing the appointment of Stéphane Varray as the new Chief Commercial Officer (CCO) and a member of the Management Committee. This content directly relates to changes in senior management personnel. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is clearly an announcement of a key executive appointment, fitting the MANG category perfectly.
2024-08-08 English
PolyPeptide appoints Chief Commercial Officer
Board/Management Information Classification · 100% confidence The document is a short press release dated August 8, 2024, announcing the appointment of a new Chief Commercial Officer (CCO), Stéphane Varray, and detailing his background and the strategic rationale for the hire. This type of announcement, concerning changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2024-08-08 English
PolyPeptide ernennt Chief Commercial Officer
Board/Management Information Classification · 100% confidence The document is a press release dated August 8, 2024, announcing the appointment of Stéphane Varray as the new Chief Commercial Officer (CCO) and a member of the Management Committee. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. The document is short and clearly structured as a media release, not a comprehensive financial report like a 10-K or IR. Therefore, the appropriate code is MANG.
2024-08-08 German
PolyPeptide announces results of the annual General Meeting 2024
AGM Information Classification · 100% confidence The document explicitly states in the title and body that it announces the 'results of the annual General Meeting 2024' (AGM 2024). It details shareholder approvals, re-elections of the Board of Directors, and mentions the AGM context throughout. This directly corresponds to the definition of 'AGM Information' (Code: AGM-R). Although it mentions approval of financial statements, the primary focus and context is the meeting outcome itself, not the full financial report (10-K or IR).
2024-04-10 English
PolyPeptide announces results of the annual General Meeting 2024
AGM Information Classification · 99% confidence The document explicitly states in the title and body that it announces the 'results of the annual General Meeting 2024' (AGM 2024). It details shareholder approvals, re-elections of the Board of Directors, and voting outcomes. This content directly corresponds to the definition of AGM Information, which is classified as 'AGM-R'. Although it mentions approvals of financial statements, the primary focus and context are the meeting results themselves.
2024-04-10 English
PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2024 bekannt
AGM Information Classification · 98% confidence The document is a press release titled "PolyPeptide gibt Ergebnisse der ordentlichen Generalversammlung 2024 bekannt" (PolyPeptide announces results of the 2024 Annual General Meeting). It details the outcomes of the shareholder votes, including the re-election of board members and the approval of various management and financial reports for the fiscal year 2023. The key phrase is 'ordentlichen Generalversammlung' (Annual General Meeting). This directly corresponds to the AGM Information category (AGM-R), which covers presentations and materials shared during the AGM. Although it reports the results, the primary subject is the meeting itself, making AGM-R the most specific fit over a general Regulatory Filing (RNS) or a Declaration of Voting Results (DVA), as it summarizes the entire event's outcome.
2024-04-10 German

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.